View Older Stories View More Recent Stories

Jan 6, 2025 06:00AM Hims and Hers (HIMS) PT Raised to $31 at Needham, Top Pick for 2025 in Digital Health

Dec 23, 2024 05:15AM Hims & Hers Health, Inc. (HIMS) call put ratio 1.4 calls to 1 put with focus on January 27.50 and 35 calls

Dec 19, 2024 09:13AM Hims & Hers Health (HIMS) Quickly Falls 9% after FDA Says the Obesity Drug Shortage Ended

Dec 18, 2024 03:09PM Hunterbrook Media is short Hims & Hers (HIMS)

Dec 18, 2024 01:46PM Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.6 puts with focus on December 29 puts

Dec 17, 2024 03:28PM Hims & Hers Health, Inc. (HIMS) option IV increases

Dec 17, 2024 10:24AM Hims & Hers Health, Inc. (HIMS) call put ratio 2.2 calls to 1 puts with focus on December 32 calls

Dec 17, 2024 05:53AM Hims & Hers Health, Inc. (HIMS) December IV bid on call put ratio 1.1 calls to 1 puts

Dec 17, 2024 04:28AM Morgan Stanley Starts Hims and Hers (HIMS) at Overweight

Dec 16, 2024 04:55AM Hims & Hers Health, Inc. (HIMS) option implied volatility near upper end of range

Dec 11, 2024 02:52PM Hims & Hers Health, Inc. (HIMS) December option implied volatility elevated

Dec 11, 2024 08:13AM Hims & Hers Health, Inc. (HIMS) falls 7% as Ro says it is working with Eli Lilly to streamline access to Zepbound

Dec 11, 2024 04:35AM Hims & Hers Health, Inc. (HIMS) spreader active in December 21 and 26 puts

Dec 3, 2024 07:22AM Hims and Hers (HIMS) PT Raised to $40 at Nephron, 'Increasing Subscriber Outlook & Target Price'

Dec 2, 2024 07:59AM Hims and Hers (HIMS) PT Raised to $38 at Canaccord Genuity

Nov 25, 2024 11:26AM Hims & Hers Health (HIMS) Mentioned as Long by Short Seller Hunterbrook

Nov 25, 2024 09:45AM BofA Securities on Hims and Hers (HIMS): 'Trump’s FDA nominee currently works for a GLP-1 compounder'

Nov 21, 2024 03:26PM Hims & Hers Health, Inc. (HIMS) Trades at High, Up 12%

Nov 21, 2024 12:02PM Hims & Hers Health (HIMS) Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys

Nov 21, 2024 05:17AM Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.5 puts on active option volume of 101K contracts

Nov 20, 2024 03:08PM Archegos Founder Bill Hwang Sentenced To 18 Years In Prison

Nov 20, 2024 07:40AM TD Cowen Reiterates Buy Rating on Hims and Hers (HIMS)

Nov 18, 2024 05:44AM Hims & Hers Health, Inc. (HIMS) call put ratio 1.1 calls to 1 put amid wide price movement

Nov 15, 2024 10:56AM Hims & Hers Health, Inc. (HIMS) call put ratio 1.1 calls to 1 put as share price down 5.2%

Nov 15, 2024 08:05AM Hims & Hers Health, Inc. (HIMS) options active on volume of 274K contracts

Nov 15, 2024 03:57AM Hims & Hers Health, Inc. (HIMS) options active on 274K contracts amid wide price movement

Nov 14, 2024 01:54PM BofA Securities Downgrades Hims and Hers (HIMS) to Underperform

Nov 14, 2024 09:57AM Increasing unusual put option volume: ZETA IGV TGTX QXO HIMS INDA MT LUNR PAGS RKLB RITM

Nov 14, 2024 08:55AM Hims & Hers Health, Inc. (HIMS) Weakness Tied to Amazon Telehealth Offering

Nov 5, 2024 07:16AM Hims and Hers (HIMS) PT Raised to $21 at Piper Sandler

Nov 5, 2024 07:12AM Hims and Hers (HIMS) PT Raised to $28 at Needham

Nov 5, 2024 06:34AM TD Cowen Reiterates Buy Rating on Hims and Hers (HIMS)

Nov 5, 2024 06:31AM Hims and Hers (HIMS) PT Raised to $24 at Citi

Nov 5, 2024 06:15AM Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)

Nov 5, 2024 05:22AM Hims and Hers (HIMS) PT Raised to $27 at BofA Securities

Nov 4, 2024 04:52PM After-hours movers: Palantir, Cleveland-Cliffs, Coinbase and more

Nov 4, 2024 04:09PM Hims & Hers Health, Inc. (HIMS) Tops Q3 EPS by 22c; beats on guidance

Oct 30, 2024 03:11PM Hims & Hers Health, Inc. (HIMS) Falls 14%

Oct 29, 2024 06:31AM Hims and Hers (HIMS) PT Raised to $26 at Leerink Partners

Oct 21, 2024 09:00AM Hims & Hers Health, Inc. (HIMS) Appoints Jessica Shepherd as Chief Medical Officer

Oct 21, 2024 05:45AM Hims and Hers (HIMS) PT Raised to $25 at BofA Securities

Oct 14, 2024 11:33AM Hims and Hers (HIMS) PT Raised to $23 at BofA Securities

Oct 14, 2024 11:19AM Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)

Oct 14, 2024 08:24AM Hims & Hers (HIMS) Climbs as FDA to Reconsider Decision Barring Compounded Versions of Eli Lilly (LLY) Weight Loss Drug

Oct 11, 2024 06:18AM Canaccord Genuity Reiterates Buy Rating on Hims and Hers (HIMS)

Oct 9, 2024 05:58AM Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)

Oct 4, 2024 05:18PM Hims & Hers Health, Inc. (HIMS) to Join S&P SmallCap 600

Oct 3, 2024 07:37AM Citi Reiterates Neutral Rating on Hims and Hers (HIMS)

Oct 3, 2024 07:27AM Hims & Hers Health (HIMS) Falls 8% as Shortage of Lilly's (LLY) Weight-Loss Drug Ends

Sep 18, 2024 09:02AM Hims & Hers Health, Inc. (HIMS) to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders

View More Recent Stories View Older Stories